Yüklüyor......
BRAF-V600E–mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor
Demonstration of BRAF-V600E in Rosai-Dorfman-Destombes disease requires sensitive molecular assays and molecular-based tissue immunostain. BRAF-V600E blood testing is important for disease-monitoring BRAF-mutated histiocytosis and can guide inhibitor treatment plans.
Kaydedildi:
| Yayımlandı: | Blood Adv |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6595264/ https://ncbi.nlm.nih.gov/pubmed/31213430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000093 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|